510(k) K212262

PCA Syringe Sets by Baxter Healthcare Corporation — Product Code FPA

K212262 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corporation for the device "PCA Syringe Sets". The FDA issued a decision of Substantially Equivalent on October 3, 2022. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Baxter Healthcare Corporation has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 3, 2022
Date Received
July 20, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Administration, Intravascular
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type